MDS Pharma Services announces new Brussels location
(June 13, 2001; Montreal, Canada) — MDS Pharma Services, one of the leading contract research organizations in the world, recently opened a new location in Brussels, Belgium, to oversee activities in Belgium and Holland. This Phase IIb, III, and IV clinical research site will monitor local studies, as well as European. This office adds to MDS' presence in Belgium with MDS Nordion located in Fleurus, Belgium.
"We are continuing to expand our global reach," said Susan Thornton, president, clinical research and central lab, MDS Pharma Services. "With facilities worldwide, combined with local experience, therapeutic expertise, and a strong commitment to excellent client service, we ensure seamless and efficient clinical research."
MDS Pharma Services is a global leader in clinical research, offering services from feasibility through regulatory submission and post-marketing studies and working diligently to customize these services. With facilities spanning four continents, each regional office is staffed with experts who bring their unique insights into the local healthcare system. MDS Pharma Services is a clinical research partner who thinks strategically about projects, anticipates clients' needs, and rapidly delivers accurate results.
From its Fleurus operation, located in the Wallonia region of Belgium, MDS Nordion supplies a variety of radioisotopes for export to nearly 75 countries. Each week the Fleurus operation contributes to helping some 50,000 people around the world as its products are used by physicians to diagnose or treat disease, such as cancer and heart disease.
MDS Pharma Services offers a full spectrum of resources to meet the drug discovery and development needs of the pharmaceutical and biotechnology industries. With facilities in more than 18 countries, the company applies advanced scientific and technological expertise to each stage of the drug discovery and development process: discovery, preclinical, early clinical research (phases I-IIa), bioanalytical, global clinical research (phases IIb-IV), and central lab.
MDS Pharma Services is part of MDS Inc. (TSE: MDS; NYSE: MDZ), an international health and life sciences company. In many of its products and services, it is among the largest and most respected companies in the world. At MDS, the focus is on fighting disease. It does this by providing laboratory testing, imaging products, research services to speed discovery and development of new drugs, therapy systems for planning and delivery of cancer treatments, analytical instruments to assist in the development of new drugs, and medical/surgical supplies. MDS employs more than 10,000 highly skilled people in its global operations on five continents. Detailed information about the company is available at the MDS Web site at www.mdsintl.com or by calling 1-888-MDS-7222, 24 hours a day.
